logo
Primary diffuse large B-cell lymphoma of the breast
Treatment of myelofibrosis in younger patients
Primary breast non-Hodgkin's lymphoma
Survival in young patients with intermediate-/high-risk myelofibrosis
Acquired pure red cell aplasia associated with malignant lymphomas
Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies
Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia
Urinary cysteinyl leukotriene E4 is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease
Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia
Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function
Antitumor activity and mechanism of action of the iron chelator, Dp44mT, against leukemic cells
Update on the therapy for myelodysplastic syndrome
Blood film features of primary myelofibrosis
Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation
A male with primary breast lymphoma
Life threatening steroid-resistant autoimmune anemia successfully treated with rituximab
Trisomy 21 in patients with acute leukemia
Incidence of hepatitis B reactivation following Rituximab therapy
Intracranial plasmacytoma mimicking meningioma in a patient with Castleman's disease
The annexin-V assay reflects susceptibility to in vitro membrane damage in chronic lymphocytic leukemia and may overestimate cell death
Novel 27.9 kb α0-thalassemia deletion in a Filipino woman